Brian M. Culley, President and CEO at Lineage Cell Therapeutics, Inc. (LCTX), bought 21,850 shares at $1.53 ($10K) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market purchase of $10k LCTX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,450 | $0 | 0.0% |
| 2 | $1.53 | 6,400 | $10K | 100.0% |
| Total | $0.45 avg | 21,850 | $10K | 100% |
| Filing → |
| LCTX | BUY | 2024-05-28 | $11K | — | Filing → |
| LCTX | BUY | 2022-03-28 | $7K | — | Filing → |
| LCTX | SELL | 2021-06-30 | $1.3M | — | Filing → |